Pharma-HCPs Relationships have been crushed to the point of being unrecognizable. This will not come as a shock to anybody – expanded tensions on limit, reclassified norms of patient collaboration and more tight administrative limitations have everything except lighted a once dynamic and direct discussion stream between makers, specialists and patients. What is less discussed […]
